Key result
Analysis of 134 livestock samples in Egypt revealed a 67.9% FMDV positivity rate, with co-circulating serotypes A and O exhibiting significant VP1 mutations that may challenge vaccine efficacy.
Why the study?
Foot-and-mouth disease virus remains a major threat to livestock in Egypt, requiring improved understanding of circulating strains to enhance control measures.
Cross-Sectional (n=134)
The study identifies circulating FMDV serotypes A and O in Egypt with mutations that may challenge vaccine effectiveness, highlighting the need for updated vaccines and surveillance.
Answers are grounded in this paper and cite their sources.
Suggests evolving FMDV strains in Egypt; leaves open whether VP1 mutations warrant vaccine reformulation pending longitudinal data.
Foot-and-mouth disease virus (FMDV) remains a major threat to livestock in Egypt, with ongoing outbreaks involving serotypes A, O, and SAT2. This study aimed to improve the understanding of these circulating FMDV strains to improve control measures. Between 2022 and 2023, 134 cattle samples from across Egypt were analyzed, revealing a 67.9% positivity rate for Pan FMDV. Of these positive samples, 64 were identified as serotype A and 27 as serotype O. Genetic analysis indicated that serotype O strains clustered within the EA-3 topotype, suggesting endemic persistence and potential vaccine evasion, while serotype A strains were associated with the African topotype and linked to regions such as Ethiopia, Kenya, and Sudan. Notable amino acid mutations in the VP1 protein of both serotypes highlighted potential challenges to vaccine effectiveness. These findings underscore the need for enhanced surveillance, timely vaccine updates, and regional cooperation to effectively manage FMD outbreaks in Egypt and neighboring countries.
No takes yet. Share an insight, caveat, or question.
Hassanein et al. (2024) conducted a cross-sectional in Foot-and-Mouth Disease (n=134). FMDV serotypes O and A was evaluated on FMDV positivity rate. Analysis of 134 livestock samples in Egypt revealed a 67.9% FMDV positivity rate, with co-circulating serotypes A and O exhibiting significant VP1 mutations that may challenge vaccine efficacy.
Synapse has enriched 10 related papers. Consider them for comparative context: